90325-47-6

Basic information

• Product Name: 1,2,3-HEXANETRIOL
• Synonyms: 1,2,3-Hexanetriol,96%;1,2,3-TRIHYDROXYHEXANE;1,2,3-HEXANETRIOL
• CAS NO: 90325-47-6
• Molecular Formula: C₆H₁₄O₃
• Molecular Weight: 134.17
• EINECS: 246-845-0
• Mol File: 90325-47-6.mol

Chemical Properties

• Melting Point: 67-69 °C(lit.)
• Boiling Point: 187.29°C (rough estimate)
• Flash Point: 147.7°C
• Appearance: /
• Density: 1.0275 (rough estimate)
• Vapor Pressure: 0.000155mmHg at 25°C
• Refractive Index: 1.4850 (estimate)
• Storage Temp.: 2-8°C
• PKA: 13.81±0.20(Predicted)
• Sensitive: Hygroscopic
• CAS DataBase Reference: 1,2,3-HEXANETRIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3-HEXANETRIOL(90325-47-6)
• EPA Substance Registry System: 1,2,3-HEXANETRIOL(90325-47-6)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• Hazardous Substances Data: 90325-47-6(Hazardous Substances Data)

Usage

Chemical Properties

white powder

InChI:InChI=1/C6H14O3/c1-2-3-5(8)6(9)4-7/h5-9H,2-4H2,1H3/t5-,6+/m1/s1

Upstream product

• 4798-44-1 1-hexene-3-ol 
• 127-08-2 potassium acetate 

Downstream Products

• 4798-44-1 1-hexene-3-ol 
• 208453-41-2 Toluene-4-sulfonic acid 2,2-dimethyl-5-propyl-[1,3]dioxolan-4-ylmethyl ester 

Relevant articles and documents

BIOOCOMPATIBLE POLYMER COMPOSITIONS

The present invention provides a biocompatible prepolymer comprising hydrophilic and hydrophobic segments, wherein the hydrophobic segments have at least one ethylenically unsaturated functional group and at least 5% of the segments have two or more ethylenically unsaturated functional groups and water. The invention further provides a biocompatible prepolymer composition comprising hydrophilic and hydrophobic prepolymers, wherein at least one of the hydrophobic prepolymers has at least one ethylenically unsaturated functional group and at least 5% of the prepolymers have two or more ethylenically unsaturated functional groups and water. The invention further provides use of the prepolymer or prepolymer compositions of the invention in biomedical applications such as tissue engineering, as bone substitutes or scaffolds, and in wound treatment.

Enhancing selectivity in oxidation catalysis with sol-gel nanocomposites

Valuable organic compounds such as α-hydroxy acids are easily synthesised with relevant selectivity enhancement using a sol-gel hydrophobized nanostructured silica matrix doped with the organocatalyst TEMPO: A materials science based synthetic route which cannot be achieved via classical homogeneous synthesis. The Royal Society of Chemistry 2005.

DERMATOLOGICAL COMPOSITIONS AND METHODS

Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.

Treatment of neurodegenerative diseases

Disclosed are methods for increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage by administration of various compounds including alcohols, diols and/or triols and their analogues.

Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway

Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.